XML 133 R119.htm IDEA: XBRL DOCUMENT v3.20.4
Condensed Financial Information - Parent Company Only - Condensed Statements of Cash Flows (Detail) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Cash Flows from Operating Activities      
Net Income $ 57,518 $ 70,672 $ 63,401
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Gain on sale of equity securities (1,213) 0 0
Provision for credit losses 27,222 2,130 4,413
Change in market value of equity securities 552 (496) 583
Excess tax (deficiencies) benefits (132) 189 318
Increase in other assets (56,639) (15,986) 2,679
Increase (decrease) in other liabilities 50,434 15,092 9,743
Net Cash Provided by Operating Activities 84,991 87,131 79,438
Cash Flows from Investing Activities      
Purchase of equity securities (2,772) (1,343) (570)
Proceeds from repayments and maturities of held to maturity securities 38,941 31,457 26,083
Proceeds from sales of equity securities 4,148 1,287 2,155
Net cash received from business acquisition 0 13,454 0
Net Cash Used in Investing Activities: (928,022) (303,977) (342,558)
Cash Flows from Financing Activities      
Cash dividends paid on common stock (25,457) (24,919) (21,307)
Purchase of treasury stock (1,452) 0 0
Retirement of restricted stock (501) (715) (763)
Exercise of stock options 0 313 307
Net Cash Provided by Financing Activities: 830,750 290,618 328,786
Net (decrease) increase in cash and cash equivalents (12,281) 73,772 65,666
Cash and cash equivalents, beginning of year 282,371 208,599 142,933
Cash and Cash Equivalents, End of Year 270,090 282,371 208,599
Parent Company      
Cash Flows from Operating Activities      
Net Income 57,518 70,672 63,401
Adjustments to reconcile net income to net cash provided by (used in) operating activities:      
Gain on sale of equity securities (149) 0 0
Amortization of subordinated debt costs 37 36 125
Provision for credit losses (12) 0 0
Change in market value of equity securities 786 (197) 338
Excess tax (deficiencies) benefits (132) 189 318
Increase in other assets (1,462) (1,873) (1,446)
Increase (decrease) in other liabilities 25 121 (6)
Equity in undistributed income of subsidiaries (32,915) (38,160) (37,454)
Net Cash Provided by Operating Activities 23,696 30,788 25,276
Cash Flows from Investing Activities      
Purchase of equity securities (49) (82) (78)
Proceeds from repayments and maturities of held to maturity securities 1,000 0 0
Proceeds from sales of equity securities 1,148 1,287 2,155
Net cash received from business acquisition 0 24 0
Net Cash Used in Investing Activities: 2,099 1,229 2,077
Cash Flows from Financing Activities      
Cash dividends paid on common stock (25,457) (24,919) (21,307)
Retirement of restricted stock (501) (715) (763)
Exercise of stock options 0 313 307
Net Cash Provided by Financing Activities: (27,410) (25,321) (21,763)
Net (decrease) increase in cash and cash equivalents (1,615) 6,696 5,590
Cash and cash equivalents, beginning of year 29,981 23,285 17,695
Cash and Cash Equivalents, End of Year $ 28,366 $ 29,981 $ 23,285